Cowen analyst, Tyler Van Buren, reiterated his Outperform rating on shares of Aerie Pharma (NASDAQ: AERI) and raised his price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst PT Change Earnings Rumors

Aerie Pharma (AERI) PT Raised to $70 at Aegis Capital Following Phase III Trial May 25, 2017 8:24 AM